Secondary pulmonary hypertension-Reference-Cited by-同舟云学术

Secondary pulmonary hypertension

Published:2001-04 Issue:2 Volume:3 Page:115-123
ISSN:1092-8464
Container-title:Current Treatment Options in Cardiovascular Medicine
language:en
Short-container-title:Curr Treat Options Cardio Med

Author:

Oudiz Ronald J.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11936-001-0067-9.pdf

Reference18 articles.

1. Executive Summary from the World Symposium on Primary Pulmonary Hypertension 1998. Edited by Rich S. URL: http://www.who.int/ncd/cvd/pph.html#NomenClass. Accessed: January 15, 2000.

2. Badesch DB, Tapson VF, McGoon MD, et al.: Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial. Ann Intern Med 2000, 132:425–434. This paper presents a well-done multicenter trial demonstrating the effectiveness of epoprostenol for pulmonary hypertension secondary to the scleroderma spectrum of diseases.

3. Olschewski H, Ghofrani HA, Schmehl T, et al.: Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH study group. Ann Intern Med 2000, 132:435–443.

4. Robbins IM, Gaine SP, Schilz R, et al.: Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus. Chest 2000, 117:14–18.

5. Klings ES, Hill NS, Leong MH, et al.: Systemic sclerosis-associated pulmonary hypertension: short- and long-term effects of epoprostenol (prostacyclin). Arthritis Rheum 1999, 42:2638–2645.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis and Management of Pulmonary Hypertension Associated with Left Ventricular Diastolic Dysfunction;Pulmonary Circulation;2012-04